In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Amneal Pharmaceuticals Inc (NASDAQ: AMRX) closed the day trading at $6.97 down -6.19% from the previous closing price of $7.43. In other words, the price has decreased by -$6.19 from its previous closing price. On the day, 2.33 million shares were traded. AMRX stock price reached its highest trading level at $7.22 during the session, while it also had its lowest trading level at $6.685.
Ratios:
For a better understanding of AMRX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.31. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on February 24, 2025, Upgraded its rating to Overweight and sets its target price to $12 from $9 previously.
On September 06, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’25 when Patel Gautam sold 80,000 shares for $8.30 per share. The transaction valued at 664,000 led to the insider holds 1,728,886 shares of the business.
Patel Tushar Bhikhubhai sold 5,000,000 shares of AMRX for $41,750,000 on Mar 14 ’25. The 10% Owner now owns 48,578,209 shares after completing the transaction at $8.35 per share. On Mar 14 ’25, another insider, Patel Tushar Bhikhubhai, who serves as the 10% Owner of the company, bought 5,000,000 shares for $8.75 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRX now has a Market Capitalization of 3466278400 and an Enterprise Value of 4832999424. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.78. Its current Enterprise Value per Revenue stands at 1.73 whereas that against EBITDA is 8.268.
Stock Price History:
The Beta on a monthly basis for AMRX is 1.19, which has changed by 0.26268113 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, AMRX has reached a high of $9.48, while it has fallen to a 52-week low of $5.18. The 50-Day Moving Average of the stock is -15.52%, while the 200-Day Moving Average is calculated to be -14.17%.
Shares Statistics:
Over the past 3-months, AMRX traded about 1.67M shares per day on average, while over the past 10 days, AMRX traded about 2270560 shares per day. A total of 309.88M shares are outstanding, with a floating share count of 137.45M. Insiders hold about 56.14% of the company’s shares, while institutions hold 36.63% stake in the company. Shares short for AMRX as of 1741910400 were 3196227 with a Short Ratio of 2.66, compared to 1739491200 on 2621816. Therefore, it implies a Short% of Shares Outstanding of 3196227 and a Short% of Float of 1.59.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
